Capital Flow Monitor · Sponsors · CIK 2125491
TelyRx Finco Inc.
333 Bay Street, Suite 2400, Toronto, A6, M5H 2T6 · 800-878-1660
Pharmaceuticals · Corporation· inc. ONTARIO, CANADA true 2026
Fit score
—
Offering
$12.6M
Sold
$12.6M
% sold
100.0%
Investors
51
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-20 | D ·current | 506(b) | $12.6M | $12.6M | 100.0% | 51 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Vanessa Slowey — Director / Executive Officer, Toronto, A6
- John Eric Cascio — Executive Officer / Director, Toronto, A6
Placement agents
- Canaccord Genuity Corp. · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.